Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 13, 2020

SELL
$16.74 - $20.68 $348,861 - $430,971
-20,840 Closed
0 $0
Q3 2019

Nov 08, 2019

SELL
$15.64 - $19.18 $8,758 - $10,740
-560 Reduced 2.62%
20,840 $367,000
Q2 2019

Aug 09, 2019

SELL
$14.73 - $17.45 $69,967 - $82,887
-4,750 Reduced 18.16%
21,400 $371,000
Q1 2019

May 14, 2019

SELL
$15.82 - $20.6 $11,865 - $15,450
-750 Reduced 2.79%
26,150 $423,000
Q4 2018

Feb 08, 2019

BUY
$17.04 - $23.5 $92,697 - $127,840
5,440 Added 25.35%
26,900 $466,000
Q3 2018

Nov 09, 2018

SELL
$20.39 - $28.03 $48,936 - $67,272
-2,400 Reduced 10.06%
21,460 $477,000
Q4 2017

Feb 09, 2018

SELL
$30.78 - $35.29 $36,936 - $42,348
-1,200 Reduced 4.79%
23,860 $745,000
Q3 2017

Nov 08, 2017

BUY
$33.01 - $34.22 $630,325 - $653,430
19,095 Added 320.12%
25,060 $854,000
Q2 2017

Aug 15, 2017

BUY
N/A
5,965
5,965 $770,000

Others Institutions Holding BAYRY

About BAYER AG SPONS ADR


  • Ticker BAYRY
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,929,700,096
  • Market Cap $26.6B
More about BAYRY
Track This Portfolio

Track Roberts Glore & CO Inc Portfolio

Follow Roberts Glore & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roberts Glore & CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Roberts Glore & CO Inc with notifications on news.